We can assist you in making sure that you are receiving the optimal financial benefit from the 340B Program relative to the inherent compliance risks of participating in the program.
We are offering a Complimentary Financial Analysis of your 340B Retail Pharmacy Program. If you would like one of our 340B consultants to analyze your retail program for possible revenue opportunities, feel free to contact us.
340B Implementation Assistance
- Provider-Based location development
- Revenue analysis
- Medicare cost report compilation
- Contract pharmacy negotiation
- 340B software selection
- HRSA registration
- Program monitoring
On April 4, CMS announced that for cost reporting periods beginning on or after October 1, 2019, providers must comply with a “longstanding” rule to claim reimbursement for crossover bad debts from the Medicare program. After this point, providers will be denied reimbursement for their crossover bad debts unless the underlying balances are logged to […]
Over the past six months, CMS instructed all MACs to complete audits of the FFY 2015 Medicare Cost Report Worksheet S-10s. Each MAC was required to complete 50 audits (approximately 25% of all DSH eligible providers nationally), and Blue & Co. represented providers in multiple MAC jurisdictions. Here’s what we learned. S-10 Audit Requests & […]
Attention 340B covered entities participating with Humana – Managed Care Medicare: Effective January 1, 2019, Humana requires that a “JG,” “TB,” or another relevant modifier be added to claims involving 340B eligible outpatient drugs under the Medicare Outpatient Prospective Payment System (OPPS) with status indicator “K.” If a claim does not include the proper modifier […]